What is UC-II?

Exploration of the therapeutic efficacy of undenatured type-II collagen (UC-II) in comparison to glucosamine and chondroitin in arthritic horses.

UC-II® stands for Undenatured Type II Collagen. It is a patented nutraceutical ingredient derived from chicken sternum cartilage.  

Unlike standard hydrolyzed collagen—which is broken down into small peptide fragments using heat or chemicals—UC-II is manufactured using a low-temperature, non-enzymatic process. This specialized processing preserves the collagen’s native triple-helix structure and keeps its biologically active molecular markers (epitopes) completely intact.  

Mechanism of Action: How it Works

Instead of acting as a metabolic building block (like hydrolyzed collagen, which provides generic amino acids for tissue repair), UC-II works biologically through a specialized immune process called oral tolerance.  

1. Interaction with the Gut (GALT)

When taken orally, the intact triple-helix structure of UC-II allows it to survive gastric digestion and reach the small intestine. There, it interacts directly with Peyer’s patches, which are microscopic clusters of lymphoid tissue forming the Gut-Associated Lymphoid Tissue (GALT).  

2. Induction of T-Regulatory Cells

The active epitopes on the native type II collagen molecule are recognized by immune cells within the Peyer's patches. Instead of triggering an inflammatory response, this specific interaction trains the immune system to recognize type II collagen as a safe, native substance. This desensitization prompts the immune system to generate T-regulatory (Treg) cells specific to type II collagen.  

3. Homing to the Inflamed Joint

These newly sensitized Treg cells migrate out of the gut via the lymphatic and circulatory systems. They specifically home in on areas where structural type II collagen is exposed, damaged, or undergoing inflammatory degradation—namely, arthritic joints.

4. Suppression of Inflammation and Degradation

Once inside the joint synovium, the Treg cells recognize the localized type II collagen and release anti-inflammatory cytokines, primarily:

• Interleukin-10 (IL-10)

• Transforming Growth Factor-beta (TGF-β)

These cytokines suppress local inflammation by downregulating pro-inflammatory pathways (such as IL-1β and TNF-α) and deactivating the matrix metalloproteinases (MMPs) responsible for chewing away at articular cartilage. By halting this auto-immune inflammatory cascade, chondrocytes can shift out of a catabolic state and better maintain joint homeostasis.

Efficacy and Clinical Outcomes in Horses

Equine clinical trials have evaluated UC-II's performance against placebos and traditional joint supplements:

• Optimal Dosage: Research demonstrates that a daily dose of 480 mg of UC-II powder (supplying approximately 120 mg of active, undenatured collagen) provides the highest therapeutic efficacy for horses suffering from osteoarthritis.  

• Pain Reduction: Clinical evaluations over a 150-day period showed up to an 88% reduction in overall pain and a 78% reduction in pain during limb manipulation (severe flexion testing).

• Comparison to Glucosamine/Chondroitin: In head-to-head equine trials, UC-II outperformed standard therapeutic doses of glucosamine (5.4 g) and chondroitin (1.8 g), proving twice as effective at mitigating lameness and arthritic pain.

• Safety Profile: Long-term administration does not alter vital signs or blood biomarkers for liver function (ALP, GGT, bilirubin) and kidney function (BUN, creatinine), demonstrating excellent tolerability.  

References

• Gupta, R. C., Canerdy, T. D., Skaggs, P., Stocker, A., Zyrkowski, G., Burke, R., ... & Bagchi, D. (2009). Therapeutic efficacy of undenatured type‐II collagen (UC‐II) in comparison to glucosamine and chondroitin in arthritic horses. Journal of Veterinary Pharmacology and Therapeutics, 32(6), 577-584.  

• Gencoglu, H., Orhan, C., Sahin, E., & Sahin, K. (2020). Undenatured type II collagen (UC-II) in joint health and disease: A review on the current knowledge of companion animals. Animals, 10(4), 697.  

• Bagchi, D., Misner, B., Bagchi, M., Kothari, S. C., Downs, B. W., Fafard, R. D., & Preuss, H. G. (2002). Effects of orally administered undenatured type II collagen against arthritic inflammatory diseases: a mechanistic exploration. International Journal of Clinical Pharmacology Research, 22(3-4), 101-110.  

• Bagi, C. M., Berryman, E. R., Teo, S., & Lane, N. E. (2017). Oral administration of undenatured native chicken type II collagen (UC-II) diminished deterioration of articular cartilage in a rat model of osteoarthritis (OA). Osteoarthritis and Cartilage, 25(12), 2080-2090.